Mobile

A phase 4 clinical study to compare the safety and efficacy of LONQUEX® with NEULASTA® and Placebo in patients with Non-Small-Cell Lung Cancer treated with first-line chemotherapy

Mise à jour : Il y a 4 ans
Référence : EUCTR2014-005096-85

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To collect comparative data for LONQUEX®, Neulasta® and placebo in patients with advanced squamous or non-squamous NSCLC Stage IIIB/IV, including full details of disease progression (whether or not leading to death) and mortality, for detailed clinical review.

Critère d'inclusion

  • Advanced squamous or non-squamous non-small-cell lung cancer (NSCLC) Stage IIIB/IV

Liens